The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 41 | 26.5x | 20.1x | Near average | |
Growth | 62 | 9.9% | 5.6% | Near average | |
Quality | 74 | 16.3% | 7.6% | Above average | |
Safety | 55 | 1.3x | 0.4x | Near average | |
Capital Return | 33 | 1.19% | 2.19% | Below average | |
Momentum | 58 | — | — | Near average | |
Sentiment | 35 | — | — | Near average |
AstraZeneca PLC is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy AstraZeneca PLC shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
AstraZeneca (AZN) has seen a positive revision in its average analyst target price, with the consensus rising from 211 to 216, representing a 2.37% increase over the last 30 days. A rare case of perfect alignment is noted between the low, high, and average target prices at 216, indicating Zero Dispersion among the 10 analysts included in the latest update. This reflects an exceptional consensus regarding the stock's fair value in the near term.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.